Research prototype, not medical advice.

In humans, low-dose rapamycin is well tolerated with modest effects.

Confidence
Debated
Level of evidence
Randomized clinical trial
Observed in
Human
Mission
Map of aging (12 hallmarks)
Concepts
Rapamycin (and analogues: everolimus)Deregulated nutrient sensing

What the sources say

Each row is an article. “Supports”: it backs the claim. “Contradicts”: it goes against it. “Qualifies”: it limits it (another species, a weaker effect…).

DirectionSourceWhere in the articleStatus
Supports Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results
Moel et al. · Aging 2025
— Verified